Physician profile
Gerard Abreo
NPI 1225072507
$12,380.43
in general payments reported to CMS, 2019-2025
55 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $1,166 · 2021: $1,361 · 2022: $1,947 · 2023: $1,808 · 2024: $2,265 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,043 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,042.69 |
| Education | $219.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,204.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $937.95 | 2019-2024 | Xarelto |
| Amgen INC. | $826.24 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $732.71 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $571.11 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $565.42 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $548.50 | 2019-2025 | Camzyos, Eliquis |
| Endologix LLC | $529.38 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $524.55 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Sanofi-Aventis U.S. LLC | $515.83 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $503.06 | 2022-2024 | Optimizer, Optimizer |
| Pfizer INC. | $438.11 | 2019-2025 | |
| Lundbeck LLC | $426.21 | 2019-2021 | |
| Esperion Therapeutics, INC. | $389.99 | 2020-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $360.43 | 2019-2025 | Lifevest |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $322.44 | 2019-2025 | Watchman Flx, Watchman Access System |
| Scpharmaceuticals INC. | $282.62 | 2025 | |
| Novo Nordisk INC | $262.33 | 2024-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $260.35 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Abiomed | $222.47 | 2024-2025 | Impella |
| Tactile Systems Technology INC | $193.89 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Arbor Pharmaceuticals, INC. | $176.45 | 2019-2022 | |
| Abbott Laboratories | $169.59 | 2020-2024 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $159.29 | 2021-2025 | |
| Gilead Sciences, INC. | $109.93 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $99.12 | 2023-2024 | Inpefa |
| Azurity Pharmaceuticals, INC. | $98.78 | 2023-2025 | Edarbi, Edarbyclor, Edarbyclor |
| Irhythm Technologies, INC. | $73.42 | 2022-2023 | Zio Xt Patch |
| Viiv Healthcare Company | $73.20 | 2019-2020 | |
| Heartflow, INC. | $60.04 | 2025 | |
| Chiesi USA, INC. | $59.69 | 2021-2022 | |
| Cvrx, INC. | $59.21 | 2023-2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $50.44 | 2022 | |
| Baxter Healthcare | $50.15 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $49.86 | 2019 | |
| Astellas Pharma US INC | $46.55 | 2019-2021 | |
| Abbvie INC. | $40.45 | 2021-2022 | |
| Allergan, INC. | $38.06 | 2020 | |
| Kestra Medical Technology Services, INC. | $36.87 | 2024-2025 | Assure Wcd |
| Lilly USA, LLC | $36.69 | 2025 | Zepbound, Mounjaro |
| Zoll Circulation INC | $25.75 | 2020 | |
| Agepha Pharma Fz LLC | $25.08 | 2024 | Lodoco |
| Lantheus Medical Imaging, INC. | $22.15 | 2023 | Definity |
| Imperative Care, INC | $22.15 | 2025 | Symphony Catheter |
| Itamar Medical INC | $22.09 | 2025 | Watchpatone |
| Paratek Pharmaceuticals, INC. | $20.52 | 2021 | |
| Covidien LP | $18.91 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $18.13 | 2024 | Arcalyst |
| Medtronic, INC. | $16.87 | 2024 | Venaseal |
| Janssen Biotech, INC. | $16.51 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.41 | 2023 | Arcalyst |
| Shionogi INC | $14.39 | 2021 | |
| Vyera Pharmaceuticals, LLC | $12.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.40 | 2020 | |
| Melinta Therapeutics, LLC | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Abreo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.